A detailed history of Claret Asset Management Corp transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Claret Asset Management Corp holds 25,181 shares of MRVI stock, worth $187,850. This represents 0.03% of its overall portfolio holdings.

Number of Shares
25,181
Previous 10,948 130.01%
Holding current value
$187,850
Previous $95,000 89.47%
% of portfolio
0.03%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.87 - $11.34 $97,780 - $161,402
14,233 Added 130.01%
25,181 $180,000
Q1 2024

Apr 29, 2024

SELL
$5.11 - $8.76 $4,404 - $7,551
-862 Reduced 7.3%
10,948 $95,000
Q4 2023

Feb 12, 2024

BUY
$4.7 - $9.87 $620 - $1,302
132 Added 1.13%
11,810 $77,000
Q2 2023

Aug 09, 2023

BUY
$12.09 - $15.0 $141,187 - $175,170
11,678 New
11,678 $145,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $981M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Claret Asset Management Corp Portfolio

Follow Claret Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claret Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Claret Asset Management Corp with notifications on news.